Earnings call transcript: Intesa Sanpaolo Q3 2026 profit tops 8.2 billion euros

Intesa Sanpaolo reported nine-month 2026 net income of EUR 8.2 billion, up 8% year over year, and raised full-year net income guidance to well above EUR 10 billion; Q3 net income was a record EUR 2.6 billion. EPS of $1.03 and revenue of $7.87 billion narrowly missed consensus of $1.05 and $7.90 billion, while the shares rose 1.28% to $40.33. The bank plans EUR 9.4 billion of 2026 dividends and buybacks and cited a 13.8% CET1 ratio; the Monte dei Paschi transaction remains subject to approvals and could incur about EUR 2.1 billion in integration charges if settlement slips into 2027.

Analysis

The key debate is earnings durability, not the small estimate miss. The fee and insurance engine can cushion rate-driven NII volatility, but management’s 2027 growth case still leans on higher Euribor, hedge roll-through and benign deposit pricing. A deposit-beta surprise or faster rate cuts would therefore hit the expected earnings trajectory even if asset quality stays sound. The market’s favorable read-through also risks treating the Monte dei Paschi transaction as value-accretive before settlement timing, remedies and the roughly EUR 2.1 billion of charges are settled; “zero integration risk” is management’s characterization, not an independently established outcome. Further branch disposals could dilute deal economics without necessarily threatening the standalone franchise.

Near term, elevated distributions and stronger guidance may support the shares, while the initial reaction has already rewarded the headline. Over 1–3 months, watch the final Italian budget-law treatment, transaction settlement and antitrust remedies, plus Q4 fee realization: performance fees are market-dependent and should not be annualized. Over 6–18 months, the central risk is that weaker rates or deposit competition offset hedge and volume gains just as acquisition costs and policy-driven taxation constrain capital returns. A contrarian read is that investors may be underpricing the asymmetry: upside from fees and hedges is gradual, while tax changes, spread widening or a delayed deal can impair confidence quickly. The thesis weakens if guidance is cut, deposit pricing accelerates, Italian sovereign spreads widen materially, or deal remedies exceed the current plan.

Key Decisions for Investors

• Treat XMIL:ISP as a selective long rather than chasing the post-results strength: consider staged entry on weakness, with the thesis tied to delivery of 2026 guidance and continued fee growth. Do not underwrite the 2027 NII outlook until deposit beta and hedge contribution are evidenced.
• Keep position risk below that of a clean domestic-bank earnings trade while the MPS transaction remains unresolved. Reassess on settlement timing, antitrust remedies and whether the EUR 2.1 billion charge lands in 2026 or 2027; larger-than-expected remedies or a material synergy/economics revision falsify the deal-upside case.
• Use the next budget-law clarification and Q4 results as near-term decision points. Reduce or exit if taxation forces a guidance cut, underlying NII weakens despite management’s rate assumptions, or fee income disappoints once market-sensitive performance fees are separated from recurring commissions.
• Avoid extrapolating headline capital returns into a permanent yield floor: monitor CET1 after distributions, transaction effects and sovereign-spread movements. A material capital-ratio deterioration or widening Italian spreads would argue for taking risk down rather than relying on the current payout narrative.